Package 72578-082-01

{"route": ["TOPICAL"], "spl_id": "ccf3671e-924e-466b-932e-f8e7ebacd4a4", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0372578082017"], "unii": ["X4HES1O11F"], "rxcui": ["197312"], "spl_set_id": ["12df1991-fb1c-45df-acf3-706b1e8ecfc3"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (72578-082-01)  / 15 g in 1 TUBE", "package_ndc": "72578-082-01", "marketing_start_date": "20200608"}, {"sample": false, "description": "1 TUBE in 1 CARTON (72578-082-06)  / 30 g in 1 TUBE", "package_ndc": "72578-082-06", "marketing_start_date": "20200608"}], "brand_name": "acyclovir", "product_id": "72578-082_ccf3671e-924e-466b-932e-f8e7ebacd4a4", "dosage_form": "OINTMENT", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72578-082", "generic_name": "acyclovir", "labeler_name": "Viona Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA205974", "marketing_category": "ANDA", "marketing_start_date": "20200608", "listing_expiration_date": "20261231"}